Bellerophon Therapeutics, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BLPH research report →
Companybellerophon.com
Bellerophon Therapeutics, Inc. , a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension.
- CEO
- Craig R. Jalbert CIRA
- IPO
- 2015
- Employees
- 18
- HQ
- Warren, NJ, US
Price Chart
Valuation
- Market Cap
- $146.79K
- P/E
- -0.01
- P/S
- 0.00
- P/B
- 0.05
- EV/EBITDA
- 0.30
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -164.21%
- ROIC
- -728.98%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-19,831,000 · -11.69%
- EPS
- $-2.08 · -11.23%
- Op Income
- $-22,384,000
- FCF YoY
- 22.13%
Performance & Tape
- 52W High
- $0.10
- 52W Low
- $0.01
- 50D MA
- $0.04
- 200D MA
- $0.05
- Beta
- 0.70
- Avg Volume
- 13.69K
Get TickerSpark's AI analysis on BLPH
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 13, 23 | Puissance Capital Management LP | sell | 1,076,841 |
| Jun 7, 23 | Amin Naseem | other | 47,578 |
| Jun 7, 23 | Fernandes Peter | other | 100,000 |
| Jun 7, 23 | Shah Parag Suresh | other | 50,000 |
| Jun 7, 23 | Dekker Martin | other | 50,000 |
| Jun 7, 23 | Bruder Scott P | other | 14,607 |
| Jun 7, 23 | Kim Bobae | other | 50,000 |
| Jun 7, 23 | Wang Theodore T | other | 14,607 |
| Jun 7, 23 | Cloyd Mary Ann | other | 14,607 |
| Jun 7, 23 | Teufel Crispin | other | 14,607 |
Our BLPH Coverage
We haven't published any research on BLPH yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate BLPH Report →